Physician profile
Rancha Exantus
NPI 1245839612
$568.29
in general payments reported to CMS, 2019-2025
9 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $27.02 · 2023: $162 · 2024: $253 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $168.47 | 2023-2024 | Farxiga, Airsupra |
| Exact Sciences Corporation | $120.29 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Viiv Healthcare Company | $117.78 | 2024-2025 | Apretude |
| Lilly USA, LLC | $46.40 | 2023-2024 | Mounjaro |
| Seqirus USA INC | $28.68 | 2024 | Flucelvax |
| Covis Pharma Gmbh | $27.02 | 2022 | |
| Gilead Sciences, INC. | $24.95 | 2025 | |
| Hologic Sales and Service, LLC | $18.75 | 2024 | Thinprep 2000 Processor, Aptima |
| Novo Nordisk INC | $15.95 | 2023 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rancha Exantus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.